175 results
Page 4 of 9
8-K
EX-99.3
elx477
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-1.1
3d6r9yers06v23sw
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.2
2nepwupjrtrhxvpjju
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
8-K
EX-99.1
1kllmzk v02n22bi
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
nqv 3c8otqql8
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
bzxmcxn fk14r
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
tefuf6hraxb50mbcj1ek
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm
8-K
EX-99.1
v9yr2fgjt ot11pn
26 Jul 21
Agile Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
y30str 6b
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
424B5
j1g mwn8zvfleudg
18 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
g4nve
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
k2v0zen5lva09an
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
zbjxnjwotakkxn2
14 Jan 21
Results of Operations and Financial Condition
8:30am
8-K
EX-99.1
7lvul
7 Dec 20
Other Events
4:30pm